Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 4 studies | 19% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1716.92 | 1445 / 1445 | 100% | 14.20 | 183 / 183 |
stomach | 100% | 1694.24 | 359 / 359 | 100% | 13.72 | 286 / 286 |
breast | 100% | 1970.33 | 459 / 459 | 100% | 16.99 | 1117 / 1118 |
bladder | 100% | 1732.62 | 21 / 21 | 100% | 14.42 | 503 / 504 |
lung | 100% | 1985.39 | 577 / 578 | 100% | 16.25 | 1154 / 1155 |
thymus | 100% | 2176.47 | 653 / 653 | 100% | 17.96 | 603 / 605 |
prostate | 100% | 1753.11 | 245 / 245 | 100% | 11.42 | 500 / 502 |
uterus | 100% | 1529.29 | 170 / 170 | 100% | 13.50 | 457 / 459 |
pancreas | 100% | 1867.48 | 328 / 328 | 99% | 14.33 | 177 / 178 |
intestine | 100% | 1834.70 | 966 / 966 | 99% | 13.94 | 523 / 527 |
kidney | 100% | 1439.82 | 89 / 89 | 99% | 14.71 | 892 / 901 |
ovary | 100% | 1165.43 | 180 / 180 | 99% | 9.40 | 424 / 430 |
adrenal gland | 100% | 1372.68 | 258 / 258 | 95% | 8.59 | 218 / 230 |
skin | 100% | 1922.85 | 1809 / 1809 | 94% | 12.65 | 443 / 472 |
brain | 93% | 570.85 | 2464 / 2642 | 100% | 11.53 | 702 / 705 |
liver | 100% | 1030.12 | 226 / 226 | 92% | 6.15 | 372 / 406 |
adipose | 100% | 1848.43 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 23.52 | 29 / 29 |
spleen | 100% | 3996.90 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.28 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.35 | 1 / 1 |
blood vessel | 100% | 1581.52 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 3254.66 | 924 / 929 | 0% | 0 | 0 / 0 |
heart | 94% | 700.41 | 809 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 74% | 6.40 | 59 / 80 |
muscle | 71% | 347.36 | 568 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002755 | Biological process | MyD88-dependent toll-like receptor signaling pathway |
GO_1990266 | Biological process | neutrophil migration |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0002224 | Biological process | toll-like receptor signaling pathway |
GO_0007254 | Biological process | JNK cascade |
GO_0045087 | Biological process | innate immune response |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0070498 | Biological process | interleukin-1-mediated signaling pathway |
GO_0038172 | Biological process | interleukin-33-mediated signaling pathway |
GO_0002446 | Biological process | neutrophil mediated immunity |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0034142 | Biological process | toll-like receptor 4 signaling pathway |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0008063 | Biological process | Toll signaling pathway |
GO_0034162 | Biological process | toll-like receptor 9 signaling pathway |
GO_0005615 | Cellular component | extracellular space |
GO_0005886 | Cellular component | plasma membrane |
GO_0019897 | Cellular component | extrinsic component of plasma membrane |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0010008 | Cellular component | endosome membrane |
GO_0005634 | Cellular component | nucleus |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005149 | Molecular function | interleukin-1 receptor binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0016301 | Molecular function | kinase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | IRAK4 |
Protein name | Interleukin 1 receptor associated kinase 4 (Interleukin-1 receptor-associated kinase 4 isoform 2) Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64) Interleukin 1 receptor associated kinase 4 Interleukin-1 receptor associated kinase 4 mutant form 2 Interleukin-1 receptor-associated kinase 4 (EC 2.7.11.1) |
Synonyms | hCG_39494 |
Description | FUNCTION: Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways . Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections. . FUNCTION: Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. . FUNCTION: Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. . |
Accessions | ENST00000551736.5 [Q9NWZ3-1] A0A8Q3SIT8 Q9NWZ3 F8VR40 ENST00000550386.5 ENST00000552309.5 F8VW24 A0A8Q3SIY0 Q7Z6A8 ENST00000550616.5 Q69FE3 ENST00000613694.5 [Q9NWZ3-1] ENST00000550615.5 ENST00000547521.5 ENST00000696791.1 ENST00000696795.1 F8VVZ1 ENST00000440781.6 [Q9NWZ3-2] ENST00000696790.1 Q7Z6A7 ENST00000696796.1 ENST00000696792.1 ENST00000550361.1 ENST00000547101.5 |